We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.21B
AUM Growth
-$47M
Cap. Flow
-$196M
Cap. Flow %
-4.66%
Top 10 Hldgs %
39.32%
Holding
820
New
134
Increased
52
Reduced
63
Closed
277

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$258M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$198M
3
FXI icon
iShares China Large-Cap ETF
FXI
+$128M
4
SEDG icon
SolarEdge
SEDG
+$63M
5
TECK icon
Teck Resources
TECK
+$57.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$131M
2
CRWD icon
CrowdStrike
CRWD
+$91.1M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$88.1M
4
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$64.4M
5
UNM icon
Unum
UNM
+$64.3M

Sector Composition

Rank Sector Weight
1 Financials 18.69%
2 Technology 11.06%
3 Industrials 6.15%
4 Consumer Discretionary 5.6%
5 Healthcare 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTAL.WS
376
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$164K ﹤0.01%
333,333
– –
ABOS icon
377
Acumen Pharmaceuticals
ABOS
$160M
$149K ﹤0.01%
27,578
-395,324
-93% -$2.66M
ALVOW icon
378
Alvotech Warrant
ALVOW
$133K ﹤0.01%
125,000
– –
GHIXW
379
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$127K ﹤0.01%
666,666
– –
RONI.WS
380
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$125K ﹤0.01%
100,000
– –
CDXS icon
381
Codexis
CDXS
$157M
$117K ﹤0.01%
25,000
– –
CORS.WS
382
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$109K ﹤0.01%
333,333
– –
GGROW
383
Gogoro Inc Warrant
GGROW
$187K
$87.5K ﹤0.01%
250,000
– –
SVIIR
384
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$85K ﹤0.01%
+500,000
New +$80.8K
HPX.WS
385
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$84K ﹤0.01%
200,000
– –
SOC.WS
386
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$81.3K ﹤0.01%
125,000
– –
GGR icon
387
Gogoro
GGR
$59.4M
$79.5K ﹤0.01%
1,250
– –
AAC.WS
388
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$74.6K ﹤0.01%
160,000
– –
SES.WS icon
389
SES AI Corp Warrants
SES.WS
$4.09M
$70.5K ﹤0.01%
133,333
– –
LVWR.WS icon
390
LiveWire Group Warrants
LVWR.WS
$6.09M
$68.8K ﹤0.01%
250,000
– –
SVIIW
391
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$62.5K ﹤0.01%
+250,000
New +$49K
CONXW
392
DELISTED
CONX Corp. Warrant
CONXW
$56.3K ﹤0.01%
375,000
– –
CIFR icon
393
Cipher Digital
CIFR
$8.84B
$56K ﹤0.01%
100,000
– –
HZON.WS
394
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$51.3K ﹤0.01%
125,000
– –
ADERW
395
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$50K ﹤0.01%
200,000
– –
SST.WS
396
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$46.4K ﹤0.01%
100,000
– –
LANV.WS
397
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$45K ﹤0.01%
+150,000
New +$39.4K
TWCBW
398
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$45K ﹤0.01%
250,000
– –
DRTSW icon
399
Alpha Tau Medical Warrant
DRTSW
$76.1M
$43.8K ﹤0.01%
175,000
– –
AMTI
400
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$42K ﹤0.01%
100,000
– –
14 15
16
17 18

Similar funds

SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return

Moore Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Moore Capital Management held 820 positions worth $4.21B, down 1.1% from $4.26B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Moore Capital Management withdrew a net $196M in Q4 2022, closing 277 positions and reducing 63 holdings. Its most notable exit was CrowdStrike, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Moore Capital Management opened a new position in State Street SPDR S&P Biotech ETF worth $264M.

  • Moore Capital Management's largest Q4 2022 buy was State Street SPDR S&P Biotech ETF: 3,182,662 shares worth $264M.
  • Moore Capital Management added most to SolarEdge in Q4 2022, an estimated $63M increase.
  • Moore Capital Management's biggest Q4 2022 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $131M.
  • Moore Capital Management fully exited CrowdStrike in Q4 2022, selling an estimated $91.1M.
  • Moore Capital Management's ten largest holdings make up 39% of its $4.21B portfolio in Q4 2022.
  • Moore Capital Management opened 134 new positions and closed 277 in Q4 2022.
  • Moore Capital Management's portfolio value fell 1.1% quarter-over-quarter to $4.21B.

Based on Moore Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.